Women who are carriers of BRCA1 mutations present with a 39–46 % lifetime risk of developing ovarian cancer, and for carriers of BRCA2 mutations the lifetime risk is 12–20 %. The gene discussed is BRCA2; the disease is ovarian carcinoma.